Gleescab Soap contains Permethrin. Gleescab Soap uses:
Gleescab Soap is indicated for the treatment of scabies.
|Brand Name:||Gleescab Soap|
|Therapeutic Class:||Parasiticidal preparations|
|Last Updated:||2020-11-20 18:15:00|
Gleescab Soap contains Permethrin 1.0 %. Gleescab Soap doses
For 15 gm Tube:
For 30 gm Tube:
In scabies patients, skin discomfort, usually described as burning, stinging or tingling occurs in a few individuals soon after the cream is applied. Other transient signs and symptoms of irritation including erythema, edema, eczema, rash and pruritus which may follow the treatment of scabies with Gleescab Soap are generally considered to be the part of the natural history of scabies. In patients treated for scabies, itching may persist for up to 4 weeks post-treatment. This is generally regarded as due to an allergic reaction to the dead mites under the skin and is not necessarily indicative of a treatment failure.
Gleescab Soap induces electrochemical abnormalities across the membranes of excitable cells, leading to sensory hyperexcitability, in coordination and prostration. Gleescab Soap is rapidly metabolized in mammals by ester hydrolysis to inactive metabolites which are excreted primarily in the urine. The principal metabolites of Gleescab Soap are detectable in the urine within hours of a whole body application of the cream to healthy volunteers or scabies patients. The highest levels of excretion are detectable within the first 48 hours, but very low levels of metabolites are still detectable in the urine of some individuals 28 days after treatment.
Gleescab Soap is not an eye-irritant, but the cream itself may cause marked irritation. Nursing staff who routinely apply Gleescab Soap, may wear gloves to avoid any possible irritation to the hands.
The treatment of eczematous-like reactions with corticosteroids should be withheld prior to treatment with Gleescab Soap, as there is a risk of exacerbating the scabies infestation by reducing the immune response to the mite.
There are limited data on the use of Gleescab Soap in pregnancy which provide no indication of any risk to the foetus. Furthermore, the amount of Gleescab Soap absorbed systemically following a whole body application is extremely low. The negative mutagenicity tests and the very low mammalian toxicity would suggest that any risk to the foetus following treatment with Gleescab Soap is minimal. Inspite of these, Gleescab Soap is suggested not to useduring pregnancy.
It is not known whether Gleescab Soap is excreted in human breast milk. So, it should not be used in nursing mothers.
Gleescab Soap is contraindicated in subjects with known hypersensitivity to the product, its components, other pyrethroids or pyrethrins.
There are no reports of overdosage with Gleescab Soap. It is possible that excessive application of Gleescab Soap might result in localized adverse reactions or more severe skin reactions.
Store at a cool and dry place. Protect from light. Do not freeze.
Gleescab Soap price in India 92.65